143 related articles for article (PubMed ID: 27637965)
21. Cognitive Changes Related to Cancer Therapy.
Vannorsdall TD
Med Clin North Am; 2017 Nov; 101(6):1115-1134. PubMed ID: 28992858
[TBL] [Abstract][Full Text] [Related]
22. Women's experiences of cognitive changes or 'chemobrain' following treatment for breast cancer: a role for occupational therapy?
Player L; Mackenzie L; Willis K; Loh SY
Aust Occup Ther J; 2014 Aug; 61(4):230-40. PubMed ID: 24499127
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy-related cognitive impairment: the breast cancer experience.
Myers JS
Oncol Nurs Forum; 2012 Jan; 39(1):E31-40. PubMed ID: 22201666
[TBL] [Abstract][Full Text] [Related]
24. Occupational Therapy's Role in Cancer Survivorship as a Chronic Condition.
Baxter MF; Newman R; Longpré SM; Polo KM
Am J Occup Ther; 2017; 71(3):7103090010P1-7103090010P7. PubMed ID: 28422624
[TBL] [Abstract][Full Text] [Related]
25. Symptoms of hormonal therapy and social support: Is there a connection? Comparison of symptom severity, symptom interference and social support among breast cancer patients receiving and not receiving adjuvant hormonal treatment.
Ochayon L; Tunin R; Yoselis A; Kadmon I
Eur J Oncol Nurs; 2015 Jun; 19(3):260-7. PubMed ID: 25529935
[TBL] [Abstract][Full Text] [Related]
26. Neurocognitive late effects of chemotherapy in children: the past 10 years of research on brain structure and function.
Anderson FS; Kunin-Batson AS
Pediatr Blood Cancer; 2009 Feb; 52(2):159-64. PubMed ID: 18680151
[TBL] [Abstract][Full Text] [Related]
27. Reliability and validity of the Childhood Cancer Survivor Study Neurocognitive Questionnaire.
Krull KR; Gioia G; Ness KK; Ellenberg L; Recklitis C; Leisenring W; Huang S; Stovall M; Robison LL; Zeltzer L
Cancer; 2008 Oct; 113(8):2188-97. PubMed ID: 18792068
[TBL] [Abstract][Full Text] [Related]
28. Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Schagen SB
Crit Rev Oncol Hematol; 2013 Oct; 88(1):87-101. PubMed ID: 23768778
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives.
Cascella M; Di Napoli R; Carbone D; Cuomo GF; Bimonte S; Muzio MR
Recenti Prog Med; 2018 Nov; 109(11):523-530. PubMed ID: 30565571
[TBL] [Abstract][Full Text] [Related]
30. Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications.
Selamat MH; Loh SY; Mackenzie L; Vardy J
PLoS One; 2014; 9(9):e108002. PubMed ID: 25259847
[TBL] [Abstract][Full Text] [Related]
31. The effect of EEG biofeedback on reducing postcancer cognitive impairment.
Alvarez J; Meyer FL; Granoff DL; Lundy A
Integr Cancer Ther; 2013 Nov; 12(6):475-87. PubMed ID: 23584550
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
Schultz PN; Klein MJ; Beck ML; Stava C; Sellin RV
J Clin Nurs; 2005 Feb; 14(2):204-11. PubMed ID: 15669929
[TBL] [Abstract][Full Text] [Related]
33. Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors.
Small BJ; Rawson KS; Walsh E; Jim HS; Hughes TF; Iser L; Andrykowski MA; Jacobsen PB
Cancer; 2011 Apr; 117(7):1369-76. PubMed ID: 21425136
[TBL] [Abstract][Full Text] [Related]
34. Neurocognitive effects of childhood cancer treatment.
Costa J
Adv Exp Med Biol; 2010; 678():26-32. PubMed ID: 20738004
[TBL] [Abstract][Full Text] [Related]
35. When do I get my brain back? Breast cancer survivors' experiences of cognitive problems.
Becker H; Henneghan A; Mikan SQ
Clin J Oncol Nurs; 2015 Apr; 19(2):180-4. PubMed ID: 25840383
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
37. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
Breckenridge LM; Bruns GL; Todd BL; Feuerstein M
Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
[TBL] [Abstract][Full Text] [Related]
38. A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog').
Raffa RB
J Clin Pharm Ther; 2011 Jun; 36(3):257-9. PubMed ID: 21545608
[TBL] [Abstract][Full Text] [Related]
39. Symptoms: Fatigue and Cognitive Dysfunction.
Bower JE; Ganz PA
Adv Exp Med Biol; 2015; 862():53-75. PubMed ID: 26059929
[TBL] [Abstract][Full Text] [Related]
40. [Impact of Treatments to Improve Cognitive Function and Quality of Life on Cancer Patients with Carcinoma of the Testes].
Vasiľková L
Klin Onkol; 2016; 29(4):267-73. PubMed ID: 27534783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
